BioAge Labs, Inc. (BIOA)
5.87
-0.07
(-1.18%)
USD |
NASDAQ |
Oct 30, 16:00
5.90
+0.03
(+0.51%)
After-Hours: 20:00
BioAge Labs Price to Book Value : 0.7167 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 0.7167 |
| October 29, 2026 | 0.7253 |
| October 28, 2026 | 0.7253 |
| October 27, 2026 | 0.6679 |
| October 26, 2026 | 0.6093 |
| October 23, 2026 | 0.6227 |
| October 22, 2026 | 0.6752 |
| October 21, 2026 | 0.6728 |
| October 20, 2026 | 0.6789 |
| October 19, 2026 | 0.6093 |
| October 16, 2026 | 0.591 |
| October 15, 2026 | 0.6532 |
| October 14, 2026 | 0.6618 |
| October 13, 2026 | 0.6801 |
| October 12, 2026 | 0.7253 |
| October 09, 2026 | 0.7741 |
| October 08, 2026 | 0.7582 |
| October 07, 2026 | 0.7643 |
| October 06, 2026 | 0.768 |
| October 05, 2026 | 0.7766 |
| October 02, 2026 | 0.8071 |
| October 01, 2026 | 0.8315 |
| September 30, 2026 | 0.8657 |
| September 29, 2026 | 0.8718 |
| September 28, 2026 | 0.8767 |
| Date | Value |
|---|---|
| September 25, 2026 | 0.8608 |
| September 24, 2026 | 0.8803 |
| September 23, 2026 | 0.9634 |
| September 22, 2026 | 1.033 |
| September 21, 2026 | 0.9878 |
| September 18, 2026 | 0.9841 |
| September 17, 2026 | 0.9878 |
| September 16, 2026 | 0.9463 |
| September 15, 2026 | 0.9988 |
| September 14, 2026 | 1.035 |
| September 11, 2026 | 1.037 |
| September 10, 2026 | 1.056 |
| September 09, 2026 | 1.120 |
| September 08, 2026 | 1.147 |
| September 04, 2026 | 1.171 |
| September 03, 2026 | 1.16 |
| September 02, 2026 | 1.188 |
| September 01, 2026 | 1.162 |
| August 31, 2026 | 1.16 |
| August 28, 2026 | 1.178 |
| August 27, 2026 | 1.231 |
| August 26, 2026 | 1.202 |
| August 25, 2026 | 1.234 |
| August 24, 2026 | 1.145 |
| August 21, 2026 | 1.158 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Neumora Therapeutics, Inc. | 1.541 |
| Alumis, Inc. | 1.913 |
| ANI Pharmaceuticals, Inc. | 2.770 |
| Corcept Therapeutics, Inc. | 12.40 |
| Veru, Inc. | 1.316 |
Price to Book Value Related Metrics
| PS Ratio | 22.57 |
| PEG Ratio | -0.3644 |
| Price | 5.87 |
| Earnings Yield | -40.66% |
| Market Cap | 268.71M |
| PEGY Ratio | -0.3644 |